<?xml version="1.0" encoding="UTF-8"?>
<ref id="B98">
 <label>98.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wen</surname>
    <given-names>Zhang</given-names>
   </name>
   <name>
    <surname>Yan</surname>
    <given-names>Zhao</given-names>
   </name>
   <name>
    <surname>Fengchun</surname>
    <given-names>Zhang</given-names>
   </name>
   <name>
    <surname>Qian</surname>
    <given-names>Wang</given-names>
   </name>
   <name>
    <surname>Taisheng</surname>
    <given-names>Li</given-names>
   </name>
   <name>
    <surname>Zhengyin</surname>
    <given-names>Liu</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Anti-inflammation treatment of severe coronavirus disease 2019 (COVID-19): from the perspective of clinical immunologists from China</article-title>. 
  <source>Clin Immunol</source>. (
  <year>2020</year>) 
  <volume>214</volume>:
  <fpage>108393</fpage>. 
  <pub-id pub-id-type="doi">10.1016/j.clim.2020.108393</pub-id>
  <?supplied-pmid 32222466?>
  <pub-id pub-id-type="pmid">32222466</pub-id>
 </mixed-citation>
</ref>
